Literature DB >> 12353510

Spina bifida and anencephaly prevalence--United States, 1991-2001.

T J Mathews, Margaret A Honein, J David Erickson.   

Abstract

Spina bifida and anencephaly are serious birth defects. To reduce the occurrence of these birth defects, the Food and Drug Administration authorized the fortification of all enriched cereal grain products with folic acid in March 1996, with compliance mandatory by January 1998. This report reviews data reported to CDC's National Center for Health Statistics (NCHS) regarding spina bifida and anencephaly prevalence for live births in the United States during 1991-2001. Since 1989, NCHS has compiled birth defect data from checkboxes that appear on birth certificates. For consistency in trends, this report uses data for 1991-2001 from all U.S. reporting areas except Maryland, New Mexico, and New York. Data for 2001 are preliminary. During 1996-2001, a 23% decline occurred in neural tube defects (spina bifida and anencephaly combined). Spina bifida declined 24% during this period, and anencephaly declined 21%. The United States has experienced declines in spina bifida and anencephaly cases since folic acid fortification of all enriched cereal grain products. The observed declines have translated into approximately 920 infants being born without these serious defects each year. Continued monitoring of the occurrence of spina bifida and anencephaly will be necessary to evaluate the effectiveness of folic acid fortification.

Entities:  

Mesh:

Year:  2002        PMID: 12353510

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  17 in total

1.  Genetic studies of the cystathionine beta-synthase gene and myelomeningocele.

Authors:  Melissa M Tilley; Hope Northrup; Kit Sing Au
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-09-28

2.  [Not Available].

Authors: 
Journal:  Paediatr Child Health       Date:  2005-07       Impact factor: 2.253

3.  Use of anencephalic newborns as organ donors.

Authors: 
Journal:  Paediatr Child Health       Date:  2005-07       Impact factor: 2.253

4.  Nationwide Trends and Variations in Urological Surgical Interventions and Renal Outcome in Patients with Spina Bifida.

Authors:  Hsin-Hsiao S Wang; Jessica C Lloyd; John S Wiener; Jonathan C Routh
Journal:  J Urol       Date:  2016-02-28       Impact factor: 7.450

5.  Population-level changes in folate intake by age, gender, and race/ethnicity after folic acid fortification.

Authors:  Tanya G K Bentley; Walter C Willett; Milton C Weinstein; Karen M Kuntz
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

6.  A cost-effectiveness analysis of folic acid fortification policy in the United States.

Authors:  Tanya Gk Bentley; Milton C Weinstein; Walter C Willett; Karen M Kuntz
Journal:  Public Health Nutr       Date:  2008-07-01       Impact factor: 4.022

7.  Emergent care patterns in patients with spina bifida: a case-control study.

Authors:  Hsin-Hsiao S Wang; John S Wiener; Sherry S Ross; Jonathan C Routh
Journal:  J Urol       Date:  2014-07-09       Impact factor: 7.450

8.  Patterns and costs of health care use of children with medical complexity.

Authors:  Eyal Cohen; Jay G Berry; Ximena Camacho; Geoff Anderson; Walter Wodchis; Astrid Guttmann
Journal:  Pediatrics       Date:  2012-11-26       Impact factor: 7.124

9.  EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment cessation.

Authors:  Konstanze Diefenbach; Dietmar Trummer; Frank Ebert; Michael Lissy; Manuela Koch; Beate Rohde; Hartmut Blode
Journal:  Int J Womens Health       Date:  2013-04-11

10.  Population prevalence, attributable risk, and attributable risk percentage for high methylmalonic acid concentrations in the post-folic acid fortification period in the US.

Authors:  Vijay Ganji; Mohammad R Kafai
Journal:  Nutr Metab (Lond)       Date:  2012-01-11       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.